Dell Emc Healthcare Powerchat

In Part I, Nathan Buchbinder, Chief Product Officer and Co-Founder at Proscia, first describes the challenges of today’s outdated practice of pathology – from a lack of trained pathologists to subjective diagnosis. He explains how hardware, software, and regulatory advancements are enabling pathology to finally overcome the hurdles of going digital. Nathan shares Proscia’s strategy for enabling pathology’s digital transformation through its Concentriq software platform for image and workflow management, AI applications, and key infrastructure partnerships, including Dell Technologies and NVIDIA. On the regulatory side, Proscia's Concentriq Dx solution was recently awarded CE mark, enabling its use for primary diagnosis in a clinical setting in Europe and other key geographies globally.